Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Shanghai Guxin Touzi

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$33M
Portfolio companies 3
Rounds per year 0.30
Lead investments 0
Exits 1
Key employees Soon

Areas of investment

  • Pharmaceutical
  • Biotechnology
  • Finance
  • Software
  • Consulting

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Shanghai Guxin Touzi:
Typical Co-investors
Shanghai Guxin Touzi is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Shanghai Guxin Touzi:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Bedford Funding Capital New York, United States, White Plains
Blue Sky Private Equity Australia, Brisbane, Queensland
Cantor Ventures New York, New York, United States
FSS Investments, LLC Louisiana, Slidell, United States
ITV England, London, United Kingdom
Lan Haiyang (Beijing) Fijin Guanli Youxian Gongsi Beijing, Beijing, China
Max Planck Innovation Bayern, Germany, Munich
MBC BioLabs California, San Francisco, United States
Mediaset Italy, Lombardy, Milan
Pelorus Venture Capital Canada, Newfoundland, St. John's
Qingchuang Investment -
Sansheng Intellectual Education Technology Beijing, China, Haidian
Shanghai Zhongfu Equity Investment Management China, Shanghai
Techammer New York, New York, United States
The Mill Las Vegas, Nevada, United States
The Toolbox Brooklyn, New York, United States
Tonghua Dongbao Pharmaceutical China, Shanxi, Tonghua
Xiaojushu Network Technology China, Shanghai
Yancey Bros. Co Austell, Georgia, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

IASO Biotherapeutics

Biotechnology
Pharmaceutical
$77M17 Jan 2023 Xuanwu District, Jiangsu, China

Joyintech

Consulting
Finance
Software
$15M12 Dec 2021 Hefei, Anhui, China

HTBT

Biopharma
Biotechnology
Manufacturing
Medical
Pharmaceutical
$7M13 Oct 2015 Shushan District, Anhui, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Shanghai Guxin Touzi?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: